Handel Carl Zeiss Meditec AG - AFX CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | 0.61 | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.017913% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | -0.004309% | ||||||||
Gebyr natten over, tid | 21:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | EUR | ||||||||
Margen | 20% | ||||||||
Aktiebørs | Germany | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
Tidligere luk* | 134.47 |
Åben* | 134.37 |
1-Års Ændring* | -12.37% |
Dagens Spænd* | 127.73 - 134.37 |
52-Ugers Spænd | 101.75-152.35 |
Gennemsnitlig Volumen (10 dage) | 101.01K |
Gennemsnitlig Volumen (3 måneder) | 1.76M |
Market Cap | 12.02B |
P/E-forhold | 39.23 |
Udestående aktier | 89.44M |
Omsætning | 1.96B |
EPS | 3.42 |
Dividend (Udbytte %) | 0.81876 |
Beta | 0.64 |
Næste indtjeningsopgørelse | May 9, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|---|---|---|---|---|---|
Mar 20, 2023 | 134.47 | -2.25 | -1.65% | 136.72 | 138.66 | 134.37 |
Mar 17, 2023 | 137.51 | 0.20 | 0.15% | 137.31 | 138.11 | 136.07 |
Mar 16, 2023 | 136.92 | 0.45 | 0.33% | 136.47 | 137.07 | 132.67 |
Mar 15, 2023 | 135.07 | -2.94 | -2.13% | 138.01 | 138.21 | 133.07 |
Mar 14, 2023 | 138.06 | 2.24 | 1.65% | 135.82 | 140.16 | 135.62 |
Mar 13, 2023 | 135.77 | 0.30 | 0.22% | 135.47 | 136.32 | 132.47 |
Mar 10, 2023 | 135.47 | 1.15 | 0.86% | 134.32 | 136.07 | 134.17 |
Mar 9, 2023 | 136.37 | 3.65 | 2.75% | 132.72 | 136.52 | 132.22 |
Mar 8, 2023 | 133.27 | -0.20 | -0.15% | 133.47 | 134.42 | 132.32 |
Mar 7, 2023 | 134.82 | -1.85 | -1.35% | 136.67 | 137.41 | 134.32 |
Mar 6, 2023 | 133.62 | 0.25 | 0.19% | 133.37 | 134.12 | 132.47 |
Mar 3, 2023 | 133.52 | 0.85 | 0.64% | 132.67 | 133.81 | 131.87 |
Mar 2, 2023 | 131.57 | 3.94 | 3.09% | 127.63 | 131.97 | 127.43 |
Mar 1, 2023 | 128.53 | 2.75 | 2.19% | 125.78 | 129.23 | 125.53 |
Feb 28, 2023 | 125.78 | -2.80 | -2.18% | 128.58 | 128.93 | 125.33 |
Feb 27, 2023 | 129.43 | -1.25 | -0.96% | 130.68 | 130.88 | 129.23 |
Feb 24, 2023 | 130.13 | -0.60 | -0.46% | 130.73 | 131.97 | 129.08 |
Feb 23, 2023 | 130.18 | -0.40 | -0.31% | 130.58 | 131.57 | 130.03 |
Feb 22, 2023 | 129.78 | -0.10 | -0.08% | 129.88 | 131.02 | 128.58 |
Feb 21, 2023 | 130.48 | -2.44 | -1.84% | 132.92 | 133.32 | 130.38 |
Carl Zeiss Meditec AG Events
Tid (UTC) (UTC) | Land | Begivenhed |
---|---|---|
No events scheduled |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total omsætning | 1646.79 | 1335.45 | 1459.32 | 1280.86 | 1189.9 |
Omsætning | 1646.79 | 1335.45 | 1459.32 | 1280.86 | 1189.9 |
Kost af omsætning, Total | 679.572 | 589.935 | 627.437 | 570.471 | 533.163 |
Bruttofortjeneste | 967.213 | 745.517 | 831.884 | 710.389 | 656.733 |
Totale Driftsudgifter | 1273.17 | 1157.9 | 1194.66 | 1083.73 | 1009.07 |
Salgs/Generelle/Admin. Udgifter, Total | 363.98 | 349.161 | 393.913 | 353.646 | 337.647 |
Forskning & Udvikling | 232.066 | 218.804 | 173.312 | 159.628 | 145.792 |
Driftsindtægter | 373.614 | 177.552 | 264.659 | 197.13 | 180.83 |
Renteindkomst (Udgift), Netto Ikke-Drift | -32.12 | -21.351 | -34.497 | -20.449 | 8.29 |
Andre, Netto | -2.444 | 22.516 | -0.304 | 2.502 | -0.564 |
Netto Indkomst Før Skat | 339.05 | 178.717 | 229.858 | 179.183 | 188.556 |
Netto Indkomst Efter Skat | 237.519 | 123.421 | 160.579 | 126.23 | 135.778 |
Minoritetsrente | -1.243 | -1.036 | -0.823 | 0.233 | -1.333 |
Netto Indkomst Før Ekstra Ting | 236.276 | 122.385 | 159.756 | 126.463 | 134.445 |
Netto Indkomst | 236.276 | 122.385 | 159.756 | 126.463 | 134.445 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 236.276 | 122.385 | 159.756 | 126.463 | 134.445 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 236.276 | 122.385 | 159.756 | 126.463 | 134.445 |
Fortyndet Netto Indkomst | 236.276 | 122.385 | 159.756 | 126.463 | 134.445 |
Fortyndet Vægtet Gennemsnit Aktier | 89.4406 | 89.4406 | 89.4406 | 89.4406 | 85.5867 |
Fortyndet EPS Uden Ekstraordinære Ting | 2.64171 | 1.36834 | 1.78617 | 1.41393 | 1.57086 |
Dividends per Share - Common Stock Primary Issue | 0.9 | 0.5 | 0.65 | 0.55 | 0.55 |
Fortyndet Normaliseret EPS | 2.62254 | 1.41621 | 1.826 | 1.44229 | 1.46924 |
Usædvanlig Udgift (Indkomst) | -2.447 | 0 | -7.478 | ||
Other Operating Expenses, Total | 0 | -0.015 | -0.058 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total omsætning | 445.229 | 410.176 | 448.585 | 430.834 | 398.456 |
Omsætning | 445.229 | 410.176 | 448.585 | 430.834 | 398.456 |
Kost af omsætning, Total | 176.654 | 177.401 | 180.772 | 169.459 | 167.701 |
Bruttofortjeneste | 268.575 | 232.775 | 267.813 | 261.375 | 230.755 |
Totale Driftsudgifter | 342.273 | 335.808 | 357.771 | 310.724 | 309.186 |
Salgs/Generelle/Admin. Udgifter, Total | 95.837 | 97.871 | 111.48 | 86.291 | 84.081 |
Forskning & Udvikling | 69.692 | 60.536 | 65.566 | 54.927 | 57.404 |
Usædvanlig Udgift (Indkomst) | 0.09 | 0 | -0.047 | 0.047 | 0 |
Driftsindtægter | 102.956 | 74.368 | 90.814 | 120.11 | 89.27 |
Renteindkomst (Udgift), Netto Ikke-Drift | -8.662 | -20.181 | -11.82 | -3.625 | -9.995 |
Andre, Netto | 25.805 | -0.115 | -1.944 | -0.217 | -0.181 |
Netto Indkomst Før Skat | 120.099 | 54.072 | 77.05 | 116.268 | 79.094 |
Netto Indkomst Efter Skat | 92.095 | 38.009 | 54.819 | 81.199 | 55.173 |
Minoritetsrente | -1.367 | -0.069 | -0.743 | 0.389 | -0.864 |
Netto Indkomst Før Ekstra Ting | 90.728 | 37.94 | 54.076 | 81.588 | 54.309 |
Netto Indkomst | 90.728 | 37.94 | 54.076 | 81.588 | 54.309 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 90.728 | 37.94 | 54.076 | 81.588 | 54.309 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 90.728 | 37.94 | 54.076 | 81.588 | 54.309 |
Fortyndet Netto Indkomst | 90.728 | 37.94 | 54.076 | 81.588 | 54.309 |
Fortyndet Vægtet Gennemsnit Aktier | 89.8297 | 89.5912 | 89.8211 | 88.6826 | 89.0312 |
Fortyndet EPS Uden Ekstraordinære Ting | 1.01 | 0.42348 | 0.60204 | 0.92 | 0.61 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0.9 | 0 | 0 |
Fortyndet Normaliseret EPS | 1.01077 | 0.42348 | 0.60167 | 0.92037 | 0.61 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 1604.02 | 1290.51 | 1304.33 | 1251.06 | 1207.89 |
Likvider og Kortsigtede Investeringer | 7.439 | 6.202 | 22.639 | 7.843 | 8.315 |
Cash | 7.439 | 6.202 | 22.639 | 6.678 | 3.925 |
Likvider & Lignende | |||||
Totale Tilgodehavender, Netto | 1294.65 | 979.93 | 1000.34 | 981.046 | 935.904 |
Accounts Receivable - Trade, Net | 185.94 | 165.158 | 205.789 | 192.33 | 195.256 |
Total Inventory | 286.375 | 286.36 | 268.322 | 248.092 | 234.303 |
Prepaid Expenses | 9.502 | 8.144 | 10.759 | 9.352 | 9.986 |
Other Current Assets, Total | 6.049 | 9.871 | 2.266 | 4.723 | 19.38 |
Total Assets | 2395.97 | 2014.85 | 2022.13 | 1662.05 | 1623.11 |
Property/Plant/Equipment, Total - Net | 199.555 | 135.265 | 116.752 | 62.632 | 58.696 |
Property/Plant/Equipment, Total - Gross | 379.88 | 320.308 | 280.47 | 196.305 | 174.346 |
Accumulated Depreciation, Total | -180.325 | -185.043 | -163.718 | -133.673 | -115.65 |
Goodwill, Net | 328.714 | 326.51 | 338.094 | 185.638 | 174.313 |
Intangibles, Net | 153.698 | 145.221 | 144.336 | 74.087 | 68.491 |
Long Term Investments | 6.713 | 4.108 | 5.173 | 0.122 | 19.3 |
Note Receivable - Long Term | 9.191 | 9.225 | 10.961 | 9.29 | 14.565 |
Other Long Term Assets, Total | 94.079 | 104.014 | 102.484 | 79.227 | 79.855 |
Total Current Liabilities | 448.118 | 297.584 | 339.6 | 280.18 | 316.078 |
Accounts Payable | 145.465 | 91.679 | 118.12 | 101.437 | 100.463 |
Accrued Expenses | 137.816 | 109.294 | 115.657 | 98.181 | 80.259 |
Notes Payable/Short Term Debt | 0.645 | 0.209 | 0.192 | 15.71 | 5.733 |
Current Port. of LT Debt/Capital Leases | 19.341 | 15.512 | 14.661 | 3.529 | 2.819 |
Other Current Liabilities, Total | 144.851 | 80.89 | 90.97 | 61.323 | 126.804 |
Total Liabilities | 736.641 | 583.133 | 623.69 | 368.588 | 407.731 |
Total Long Term Debt | 178.425 | 140.636 | 151.837 | 7.321 | 3.588 |
Long Term Debt | 76.496 | 87.543 | 109.009 | 0 | 0.593 |
Capital Lease Obligations | 101.929 | 53.093 | 42.828 | 7.321 | 2.995 |
Deferred Income Tax | 15.438 | 17.166 | 18.198 | 5.234 | 8.918 |
Minority Interest | 18.056 | 18.841 | 18.517 | 21.17 | 26.358 |
Other Liabilities, Total | 76.604 | 108.906 | 95.538 | 54.683 | 52.789 |
Total Equity | 1659.33 | 1431.72 | 1398.44 | 1293.46 | 1215.38 |
Common Stock | 89.441 | 89.441 | 89.441 | 89.441 | 89.441 |
Additional Paid-In Capital | 620.137 | 620.137 | 620.137 | 620.137 | 620.137 |
Retained Earnings (Accumulated Deficit) | 1000.48 | 808.922 | 744.673 | 632.486 | 555.215 |
Other Equity, Total | -50.729 | -86.783 | -55.812 | -48.6 | -49.416 |
Total Liabilities & Shareholders’ Equity | 2395.97 | 2014.85 | 2022.13 | 1662.05 | 1623.11 |
Total Common Shares Outstanding | 89.4406 | 89.4406 | 89.4406 | 89.4406 | 89.4406 |
Kortsigtede Investeringer | 0 | 1.165 | 4.39 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 1674.57 | 1604.02 | 1451.74 | ||
Likvider og Kortsigtede Investeringer | 21.589 | 17.918 | 17.352 | ||
Likvider & Lignende | 8.401 | 7.439 | 8.315 | ||
Kortsigtede Investeringer | 13.188 | 10.479 | 9.037 | ||
Totale Tilgodehavender, Netto | 1298.01 | 1274.3 | 1140.1 | ||
Accounts Receivable - Trade, Net | 156.475 | 185.94 | 164.928 | ||
Total Inventory | 328.867 | 286.375 | 274.078 | ||
Other Current Assets, Total | 26.105 | 25.422 | 20.211 | ||
Total Assets | 2526.01 | 2395.97 | 2217.7 | ||
Property/Plant/Equipment, Total - Net | 205.703 | 199.555 | 189.302 | ||
Goodwill, Net | 379.934 | 328.714 | 323.349 | ||
Intangibles, Net | 163.484 | 153.698 | 144.045 | ||
Long Term Investments | 6.843 | 6.713 | 4.843 | ||
Note Receivable - Long Term | 9.096 | 9.191 | 8.339 | ||
Other Long Term Assets, Total | 86.374 | 94.079 | 96.077 | ||
Total Current Liabilities | 499.258 | 448.118 | 347.866 | ||
Accounts Payable | 140.474 | 145.465 | 123.336 | ||
Accrued Expenses | 109.277 | 127.787 | 92.307 | ||
Notes Payable/Short Term Debt | 0 | 0 | 0 | ||
Current Port. of LT Debt/Capital Leases | 18.97 | 19.341 | 17.876 | ||
Other Current Liabilities, Total | 230.537 | 155.525 | 114.347 | ||
Total Liabilities | 788.612 | 736.641 | 672.152 | ||
Total Long Term Debt | 189.666 | 178.425 | 192.216 | ||
Long Term Debt | 88.588 | 76.496 | 90.194 | ||
Capital Lease Obligations | 101.078 | 101.929 | 102.022 | ||
Deferred Income Tax | 15.035 | 15.438 | 16.932 | ||
Minority Interest | 18.693 | 18.056 | 17.705 | ||
Other Liabilities, Total | 65.96 | 76.604 | 97.433 | ||
Total Equity | 1737.39 | 1659.33 | 1545.55 | ||
Common Stock | 89.441 | 89.441 | 89.441 | ||
Additional Paid-In Capital | 620.137 | 620.137 | 620.137 | ||
Retained Earnings (Accumulated Deficit) | 1048.65 | 1000.48 | 909.534 | ||
Other Equity, Total | -20.833 | -50.729 | -73.565 | ||
Total Liabilities & Shareholders’ Equity | 2526.01 | 2395.97 | 2217.7 | ||
Total Common Shares Outstanding | 89.4406 | 89.4406 | 89.4406 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netto indkomst/Startlinje | 237.519 | 123.421 | 160.579 | 126.23 | 135.778 |
Likvider Fra Driftsaktiviteter | 362.663 | 178.527 | 219.634 | 187.207 | 37.732 |
Likvider Fra Driftsaktiviteter | 61.584 | 60.425 | 48.37 | 31.282 | 24.235 |
Ikke-Likvide Ting | 110.074 | 58.691 | 76.373 | 54.526 | 47.269 |
Cash Taxes Paid | 97.908 | 58.964 | 65.07 | 48.364 | 54.73 |
Likvid Rente Betalt | 1.629 | 1.365 | 1.903 | 1.94 | 1.559 |
Ændringer i Driftskapital | -46.514 | -64.01 | -65.688 | -24.831 | -169.55 |
Likvider fra Investeringsaktiviteter | -75.2 | -70.947 | -145.846 | -28.874 | -55.931 |
Kapitaludgifter | -66.101 | -44.986 | -46.711 | -34.756 | -39.022 |
Andre Investerings-Cash-Flow-Ting, Total | -9.099 | -25.961 | -99.135 | 5.882 | -16.909 |
Likvider fra Financieringsaktiviteter | -285.889 | -122.961 | -58.637 | -157.237 | 14.494 |
Financiering af Cash-Flow-Ting | -223.862 | -48.775 | 4.321 | -104.529 | -259.854 |
Total Cash Dividends Paid | -44.72 | -58.136 | -49.192 | -49.192 | -37.565 |
Udstedelse (Pensionering) af Gæld, Netto | -17.307 | -16.05 | -13.766 | -3.516 | -3.123 |
Udenlandsk Børs Effekter | -0.337 | -1.056 | 0.81 | 1.657 | -1.08 |
Netto Ændring i Likviditet | 1.237 | -16.437 | 15.961 | 2.753 | -4.785 |
Udstedelse (Pensionering) af Aktier, Netto | 0 | 315.036 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 130.104 | 101.501 | |||
Cash From Operating Activities | 74.484 | 151.878 | |||
Cash From Operating Activities | 33.045 | 29.924 | |||
Non-Cash Items | 16.671 | 44.673 | |||
Cash Taxes Paid | 61.722 | 41.015 | |||
Cash Interest Paid | 0.679 | 0.67 | |||
Changes in Working Capital | -105.336 | -24.22 | |||
Cash From Investing Activities | -54.311 | -28.769 | |||
Capital Expenditures | -35.335 | -23.26 | |||
Other Investing Cash Flow Items, Total | -18.976 | -5.509 | |||
Cash From Financing Activities | -18.33 | -124.663 | |||
Financing Cash Flow Items | -9.441 | -116.396 | |||
Issuance (Retirement) of Debt, Net | -8.889 | -8.267 | |||
Foreign Exchange Effects | -0.881 | -0.31 | |||
Net Change in Cash | 0.962 | 2.113 |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
Carl Zeiss Group | Corporation | 59.14 | 52895153 | 35776 | 2022-11-15 | |
Capital Research Global Investors | Investment Advisor | 4.9912 | 4464153 | -46868 | 2023-02-13 | LOW |
Capital World Investors | Investment Advisor | 1.6403 | 1467117 | 0 | 2023-01-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.1486 | 1027305 | 1286 | 2023-02-28 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 0.8941 | 799668 | -11471 | 2023-01-31 | LOW |
Groupama Asset Management | Investment Advisor | 0.8665 | 775034 | -37628 | 2022-09-30 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.7614 | 681009 | -125 | 2023-02-28 | LOW |
BlackRock Asset Management Deutschland AG | Investment Advisor | 0.7572 | 677231 | -8165 | 2023-02-28 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.7341 | 656620 | -14037 | 2023-02-28 | LOW |
Allianz Global Investors GmbH | Investment Advisor | 0.6837 | 611545 | -19183 | 2023-01-31 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 0.5952 | 532334 | 153016 | 2023-02-28 | HIGH |
Candriam Luxembourg S.A. | Investment Advisor | 0.5894 | 527175 | -10543 | 2023-01-31 | HIGH |
La Financière de l'Echiquier | Investment Advisor | 0.5405 | 483394 | -6 | 2022-11-30 | LOW |
Oddo BHF Asset Management S.A.S | Investment Advisor/Hedge Fund | 0.4626 | 413722 | -16606 | 2023-01-31 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.442 | 395285 | 17110 | 2023-02-28 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.4095 | 366292 | -451602 | 2022-12-31 | LOW |
Deka Investment GmbH | Investment Advisor/Hedge Fund | 0.332 | 296921 | -10699 | 2023-02-28 | LOW |
Credit Mutuel Asset Management | Investment Advisor | 0.2971 | 265728 | 250534 | 2022-12-31 | HIGH |
Columbia Threadneedle Investments (UK) | Investment Advisor/Hedge Fund | 0.2487 | 222410 | -1214 | 2022-11-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.2357 | 210844 | 1186 | 2023-01-31 | LOW |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group500K+
Handlende
92K+
Månedlkige, aktive klienter
$53M+
Månedlig investeringsvolumen
$30M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Carl Zeiss Meditec Company profile
Om Carl Zeiss Meditec AG
Carl Zeiss Meditec AG er en tysk virksomhed inden for medicinsk teknologi og medicinsk udstyr. Virksomheden tilbyder komplette løsninger til diagnosticering og behandling af oftalmiske sygdomme, visualiseringsløsninger til mikrokirurgi og andre teknologier, såsom intraoperativ strålebehandling. Virksomheden opererer i to segmenter: Ophthalmisk udstyr og mikrokirurgi. Segmentet Ophthalmic Devices omfatter aktiviteter inden for oftalmologi, f.eks. intraokulære linser, kirurgiske visualiseringsløsninger og medicinske laser- og diagnosesystemer. Segmentet Mikrokirurgi omfatter aktiviteter inden for neuro-, øre-, næse- og halskirurgi samt aktiviteter inden for intraoperativ stråling. Selskabet har forskellige produktionssteder i Europa, USA og Asien.
Industry: | Advanced Medical Equipment & Technology (NEC) |
Göschwitzer Straße 51-52
07745
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com